Paxlovid in COVID-19 Vaccinated patients

Join us as we explore new trial data examing Paxlovid's effectiveness in high-risk, vaccinated patients.  The GameChangerSignificantly high risk patients are still at risk from active Covid-19 infection. A new trial looks at Paxlovid use in high-risk, vaccincated patients. HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health ReferenceNew England Journal of Medicine Article Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss EPIC SR study findings.2. Describe benefits of Paxlovid for specific patient groups based on trial data.0.05 CEU/0.5 HrUAN: 0107-0000-24-172-H01-PInitial release date: 05/13/2024Expiration date: 05/13/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram